Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Universita' degil Syudi di Modena e Reggio Emilia is active in the Biotechnology & Pharmaceuticals technology area. The current state of their patent prosecution is concentrated, with 1 pending office action currently in progress. This reflects a specific point of engagement with the patent office regarding their research-driven intellectual property and suggests a deliberate pace in their patenting activities.
The portfolio's prosecution is handled by a distinct examiner and is situated within a distinct art unit. This indicates that the technical merits of the university's current applications are being evaluated by a specialized reviewer. CHICKS, ASHLI ARIANA is the busiest examiner for the organization, currently managing 1 pending office action. Because this examiner is the only individual currently reviewing the university's work, the success of their immediate patenting goals depends on the specific requirements and examination style of this individual, which is a common scenario for academic institutions with focused portfolios.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHICKS, ASHLI ARIANA | 1 | 60.0% | +51.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18548766 | BETA-LACTOMASE INHIBITORS AND USES THEREOF | CHICKS, ASHLI ARIANA | 26d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18548766 | BETA-LACTOMASE INHIBITORS AND USES THEREOF | CHICKS, ASHLI ARIANA | 26d |
| Art Unit | Apps |
|---|---|
| 1626 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18548766 | BETA-LACTOMASE INHIBITORS AND USES THEREOF | CHICKS, ASHLI ARIANA | 1626 | §102§103§112 | Non-Final OA | 26d | Pending | Sep 01, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversita' degil Syudi di Modena e Reggio Emilia has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Ashli Ariana Chicks has the most, with 1 of Universita' degil Syudi di Modena e Reggio Emilia's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
